Clinical trial
Corticosteroid Therapy of Septic Shock - Corticus
NCT00147004 · Hadassah Medical Organization, Other · Completed
Key facts
| NCT number | NCT00147004 |
|---|---|
| Title | Corticosteroid Therapy of Septic Shock - Corticus |
| Official title | Corticosteroid Therapy of Septic Shock - Corticus. A Multi-National, Prospective, Double-Blind, Randomized, Placebo-Controlled Study |
| Acronym | Corticus |
| Lead sponsor | Hadassah Medical Organization, Other |
| Collaborators | European Society of Intensive Care Medicine International Sepsis Forum The Gorham Foundation |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Shock, Septic |
| Intervention type | Drug |
| Interventions | hydrocortisone sodium succinate, Placebo |
| Enrollment | 500 |
| Start date | Mar 1, 2002 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Sep 7, 2005 |
| Last update posted | Apr 24, 2008 |
| Countries | Austria, Belgium, France, Germany, Israel, Italy, Netherlands, Portugal, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: